CSF3 and neoplasm: The results showed that G-CSF/IL-6 could not antagonize the priming effect of IFN-γ/TNF-α, evaluated by the activation of signaling pathways, MPO release, and tumor-suppressing effect of neutrophils (Supplemental Figure S6).